BB BIOTECH AG

13D and 13G Filings

Issuer % of Class Filed
Schedule 13G · 5 securities · passive
Agios Pharmaceuticals, Inc. 13G/A
AGIO · 00847X104
0% 6/13/2025
Event 6/1/2025
MacroGenics, Inc. 13G/A
MGNX · 556099109
0% 6/13/2025
Event 6/1/2025
Black Diamond Therapeutics, Inc. 13G/A
BDTX · 09203E105
4.8% 3/21/2025
Event 3/19/2025
Esperion Therapeutics, Inc. 13G/A
ESPR · 29664W105
4.9% 3/10/2025
Event 3/4/2025
Sage Therapeutics, Inc. 13G/A
SAGE · 78667J108
1.9% 1/17/2025
Event 1/13/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.